Occlusion with high plus corneal lenses.

Por Catford, G V, Mackie, I A
Publicado em 1968

Quantitative tear lysozyme assay in units of activity per microlitre.

Por Mackie, I. A., Seal, D. V.
Publicado em 1976

The questionably dry eye.

Por Mackie, I. A., Seal, D. V.
Publicado em 1981

Surface changes in the anaesthetic conjunctiva in man, with special reference to the production of mucus from a non-goblet-cell source.

Por Dilly, P. N., Mackie, I. A.
Publicado em 1981

Diagnostic implications of tear protein profiles.

Por Mackie, I A, Seal, D V
Publicado em 1984

Distribution of tetracycline in the conjunctiva of patients on long term systemic doses.

Por Dilly, P N, Mackie, I A
Publicado em 1985

Tear fluid lysozyme concentration: guide to practolol toxicity.

Por Mackie, I A, Seal, D V
Publicado em 1975

Effects of long-term treatment with timolol on lacrimal gland function.

Por Coakes, R L, Mackie, I A, Seal, D V
Publicado em 1981

Beta-adrenergic receptor blocking drugs: tear lysozyme and immunological screening for adverse reaction.

Por Mackie, I. A., Seal, D. V., Pescod, J. M.
Publicado em 1977

Quantitative tear lysozyme assay: a new technique for transporting specimens.

Por Seal, D V, Mackie, I A, Coakes, R L, Farooqi, B
Publicado em 1980

Bacteriology and tear protein profiles of the dry eye.

Por Seal, D V, McGill, J I, Mackie, I A, Liakos, G M, Jacobs, P, Goulding, N J
Publicado em 1986